Abstract
We studied loss of heterozygosity (LOH) on the long arm of human chromosome 18 in prostate cancer to determine the location of a putative tumor suppressor gene (TSG) and to correlate these losses with the pathological grade and stage of the cancer. Of 48 specimens analysed 17 (35.4%) lost at least one allele on chromosome 18q. All the specimens with allelic losses lost at least one allele within chromosomal region 18q21. Allelic losses picked at D18S51 (19%) and D18S858 (17%). A 0.58 cM DNA segment that includes the D18S858 locus and is flanked by the microsatellite loci D18S41 and D18S381, was lost in eight (47%) of 17 specimens with allelic losses. This segment was designated as a LOH cluster region 1 (LCR 1). Although Smad2 resides within LCR 1, it was not mutated in any of the six prostate cell lines (five prostate cancer cell lines and one immortalized prostate epithelial cell line) analysed, suggesting that it is not a candidate TSG in prostate cancer. A second LCR at 18q21, LCR 2, includes the D18S51 locus and is flanked by the D18S1109 and D18S68 loci, which are separated by 7.64 cM. LCR 2 was lost in six (35%) of the 17 specimens with chromosome 18q losses. These results suggest that chromosome 18q21 may harbor two candidate prostate cancer TSGs. The candidate TSGs DCC and Smad4 are located centromeric to the LCRs. No alleles were lost within or in close proximity to these genes, suggesting that they are not targets for inactivation by allelic losses in prostate cancer. Although there was no obvious correlation between chromosome 18q LOH and the pathological grade or stage, three (37.5%) of eight low-grade cancers and nine (32.1%) of 28 organ-confined cancers lost alleles at 18q21, suggesting that allelic losses are relatively early events in the development of invasive prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alexandrow MG, Moses HL . 1995 Cancer Res. 55: 1452–1457
Bergerheim US, Kunimi K, Collins VP, Ekman P . 1991 Genes Chromosomes Cancer. 3: 215–220
Bova GS, Carter BS, Bussemakers MJG, Emi M, Fujiwara Y, Kiprianou N, Jacobs SC, Robinson JC, Epstein JI, Walsh PC, Isaacs WB . 1993 Cancer Res. 53: 3869–3871
Brewster SF, Gingell JC, Browne S, Brown KW . 1994 Br. J. Cancer 70: 697–700
Brooks JD, Bova GS, Ewing CM, Piantadosi S, Carter BS, Robinson JC, Epstein JI, Isaacs WB . 1996 Cancer Res. 56: 3814–3822
Cairns P, Okami K, King P, Bonacum J, Ahrendt S, Wu L, Mao L, Jen J, Sidransky D . 1997 Cancer Res. 57: 5356–5359
Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB . 1990 Proc. Natl. Acad. Sci. USA 87: 8751–8755
Chenevix-Trench G, Leary J, Kerr J, Michel J, Kefford R, Hurst T, Parson PG. Friedlander M, Khoo SK . 1992 Oncogene 7: 1059–1065
Cho KR, Oliner JD, Simons JW, Hedrick L, Fearon ER, Preisinger AC, Hedge P, Sikernian GA, Vogelstein B . 1994 Genomics 19: 525–531
Cliby W, Ritland S, Hartmann L, Dodson M, Hailing KC, Keeney G, Podrats KC, Jenkins RB . 1993 Cancer Res. 53: 2393–2398
Collins A, Frezal J, Teague J, Morton NE . 1996 Proc. Natl. Acad. Sci. USA 93: 14771–14775
Cooney KA, Wetzel JC, Merajver SD, Macoska JA, Singleton TP, Wojno KJ . 1996 Cancer Res. 56: 1142–1145
Cropp CS, Lidereau R, Campbell G, Champene MH, Callahan R . 1990 Proc. Natl. Acad. Sci. USA 87: 7737–7741
Crundwell MC, Chughtai S, Knowles M, Takle L, Luscombe M, Neoptolemos JP, Morton DG, Phillips SMA . 1996 Int. J. Cancer 69: 295–300
Cunningham JM, Shan A, Wick MJ, McDonnell SK, Schaid DJ, Tester DJ, Qian J, Takahashi S, Jenkins RB, Bostwick DG, Thibodeau SN . 1996 Cancer Res. 56: 4475–4482
Degeorges A, Hoffschir F, Cussenot O, Gauville C, Le Duc A, Dutrillaux B, Calvo F . 1995 Int. J. Cancer 62: 724–731
Devilee P, van Vliet M, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ . 1991 Oncogene 6: 311–315
Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach JA . 1996 Nature 380: 152–154
Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L . 1996 Cell 86: 543–552
Fearon ER, Cho KR, Nigro JM, Kern SE, Simons LW, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B . 1990 Science 247: 49–56
Fleming ID, Cooper JS, Henson DE, Huntter RVP, Kennedy BJ, Murphy GP, O'Sullivan B, Sobin LH, Yarbro JW (eds) . 1997 AJCC cancer staging manual fifth edition Lippincott-Raven: Philadelphia
Gao X, Horm KV, Grignon D, Sakr W, Chen YQ . 1993 Cancer Res. 53: 2723–2727
Gao X, Zacharek A, Salkowski A, Grignon DJ, Sakr W, Porter AT, Horm KV . 1995 Cancer Res. 55: 1002–1005
Gleason D . 1977 Urologic Pathology: The prostate. Tannenbaum M (ed) Lea & Febiger: Philadelphia pp. 171–197
Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE . 1998 Cancer Res. 58: 5329–5332
Hahn SA, Bartsch, Schroers A, Galehdari H, Becker M, Ramaswamy A, Schwarte-Waldhoff I, Maschek H, Schmiegel W . 1998 Cancer Res. 58: 1124–1126
Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE . 1996 Science 271: 350–353
Hahn SA, Seumour AB, Hoque MS, Schutte M, da Costa LT, Redston MS, Caldas C, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kem SE . 1995 Cancer Res. 55: 4670–4675
Hedrick L, Cho KR, Fearon ER, Wit TC, Kinzler KW, Vogelstein B . 1994 Genes Dev. 8: 1174–1183
Huang Y, Boynton RF, Blount PL, Silverstein RI, Yin Y, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ, Meltzer S . 1992 Cancer Res. 52: 6525–6530
Ittmann M . 1996 Cancer Res. 56: 2143–2147
Jenkins R, Takahashi S, DeLacey K, Bergstralh E, Lieber M . 1998 Genes Chromosomes Cancer 21: 131–143
Kagan J, Stein J, Babaian RJ, Joe YS, Pisters LL, Glassman AB, von Eschenbach AC, Troncoso P . 1995 Oncogene 11: 2121–2126
Kim SK, Fan Y, Papadimitrakopoulou V, Clayman G, Hittelman WN, Hong WK, Lotan R, Mao L . 1996 Cancer Res. 56: 2519–2521
Kong XT, Choi SH, Inoue A, Xu F, Chen T, Takita J, Yokota J, Bessho F, Yanagisawa M, Hanada R, Yamamoto K, Hayashi Y . 1997 Cancer Res. 57: 3772–3778
Kunimi K, Bergerheim US, Larsson IL, Ekman P, Collins VP . 1991 Genomics 11: 530–536
Latil A, Baron JC, Cussenot O, Fournier G, Soussi T, Boccon-Gibod L, Le Duc A, Rouesse J, Lidereau R . 1994 Genes Chromosomes Cancer 11: 119–125
Latil A, Pesche S, Valeri A, Fournier G, Cussenot O, Lidereau R . 1999 Prostate 40: 225–231
Li C, Larsson C, Futreal A, Lancaster J, Phelan C, Aspenblad U, Sundelin B, Liu Y, Ekman P, Auer G, Bergerheim US . 1998 Oncogene 16: 481–487
Li J. Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R . 1997 Science 275: 1943–1947
MacGrogan D, Levy A, Bostwick D, Wagner M, Wells D, Bookstein R . 1994 Genes Chromosomes Cancer 10: 151–159
MacGrogan D, Pegram M, Slamon D, Bookstein R . 1997 Oncogene 15: 1111–1114
Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD, Pietruk T, Powell IJ . 1995 Cancer Res. 55: 5390–5395
Melamed J, Einhorn JM, Ittmann MM . 1997 Clin. Cancer Res. 3: 1867–1872
Mottaz AE, Markwalder R, Fey MF, Klima I, Merz VW, Thalmann GN, Ball RK, Studer UE . 1997 Prostate 31: 209–215
Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudorni T, Saji S, Shimokata K, Takahashi T, Takahashi T . 1996 Cancer Res. 56: 2718–2720
Navone NM, Troncoso P, Pisters LL, Goodrow TL, Palmer JL, Nichols WW, Von Eschenbach AC, Conti CJ . 1993 J. Natl. Cancer Inst. 85: 1657–1659
Raff T, van der Giet M, Endemann D, Wiederholt T, Paul M . 1997 Biotechniques 23: 456–460
Reale MA, Hu G, Zafar AL, Getzenberg RH, Levine SM, Fearon ER . 1994 Cancer Res. 54: 4493–4501
Riggins GJ, Thiagalingarn S, Rozenblurn E, Weinstein CL, Kern SE, Hamilton SR, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B . 1996 Nat. Genet. 13: 347–349
Salem CE, Tomasic NA, Elmajian DA, Esrig D, Nichols PW, Taylor CR, Skinner DG, Roy-Burman P, Lieskovsky G, Cote RJ . 1997 J. Urology 158: 510–514
Schutte M, Hruban RH, Hedrick L, Cho KR, Nadasdy GM, Weinstein CL, Bova GS, Isaacs WB, Cairns P, Nawroz H, Sidransky D, Casero Jr RA, Meltzer PS, Hahn SA, Kern SE . 1996 Cancer Res. 56: 2527–2530
Shibagaki L, Shimada Y, Wagata T, lkenaga M, Imamura M,, Ishigaki K . 1994 Cancer Res. 54: 2995–3000
Shiseki M, Kohno T, Nishikawa R, Sameshima Y, Mizoguchi H,, Yokot J . 1994 Cancer Res. 54: 5643–5648
Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV . 1997 Nat. Genet. 15: 356–362
Suzuki H, Emi M, Komiya A, Fujiwara Y, Yatani R, Nakamura Y, Shimazaki J . 1995 Genes Chromosomes Cancer 13: 168–174
Takita J, Hayashi Y, Kohno T, Shiseki M, Yamaguchi N, Hanada R, Yamamoto K, Yokota J . 1995 Oncogene 11: 1829–1834
Teng DH, Hu R, Lin H, Davis T, Iliev D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El-Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA, et al. 1997 Cancer Res. 57: 5221–5225
Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JKV, Markowitz S, Hamilton SR, Kern SE, Kinzier KW, Vogelstein B . 1996 Nat. Genet. 13: 343–346
Trapman J, Sleddens HF, van der Weiden MM, Dinjens WN, Konig JJ, Schroder FH, Faber PW, Bosman FT . 1994 Cancer Res. 54: 6061–6064
Uchida K, Nagatake M, Osada H, Yatabe Y, Kondo M, Mitsudomi T, Masuda A, Takahashi T, Takahashi T . 1996 Cancer Res. 56: 5583–5585
Uchino S, Tusda H, Noguchi M, Yokota J, Terada M, Saito T, Kofayashi M, Sugimura T, Hirohashi S . 1992 Cancer Res. 52: 3099–3102
Ueda T, Komiya A, Emi M, Suzuki H, Shiraishi T, Yatani R, Masai M, Yasuda K, Ito H . 1997 Genes Chromosomes Cancer 20: 140–147
Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola, JJ, Kallioniemi OP . 1995 Cancer Res. 55: 342–347
Vogelstein B, Fearon E, Kern S, Hamilton S, Preisinger A, Nakamura Y, White R, Smits AM, Bos JL . 1988 N. Eng. J. Med. 319: 525–532
Weinberg RA . 1991 Science 254: 1138–1146
Yin Z, Spitz MR, Babaian RJ, Strom SS, Trocoso P, Kagan J . 1999 Oncogene 18: 7576–7583
Zar JH . 1991 Biostatistical analysis Prentice Hall: Englewood Cliffs, NJ
Zenklusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ . 1994 Cancer Res. 54: 6370–6373
Zhang Y, Feng XH, Wu RY, Derynck R . 1996 Nature 383: 168–172
Acknowledgements
This study was supported by NCI grant CA68578-05(J Kagan and MR Spitz) and by The University of Texas M.D. Anderson Cancer Center Physician Referral Service Award (J Kagan).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yin, Z., Babaian, R., Troncoso, P. et al. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene 20, 2273–2280 (2001). https://doi.org/10.1038/sj.onc.1204310
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204310
Keywords
This article is cited by
-
Genistein downregulates onco-miR-1260b and upregulates sFRP1 and Smad4 via demethylation and histone modification in prostate cancer cells
British Journal of Cancer (2014)
-
TGF-β – an excellent servant but a bad master
Journal of Translational Medicine (2012)
-
Recurrent chromosomal abnormalities in human embryonic stem cells
Nature Biotechnology (2008)